Effects of CJX1, an amlodipine derivative, on ATPase activity of human P-glycoprotein in resistant tumor cells

Chinese Pharmacological Bulletin

Volumn 24, Issue 12, 2008, Pages 1603-1606

  Ji, Bian Sheng ^a   He, Ling ^b  

^a HENAN UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

ATPase; CJX1; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMLODIPINE; CJX 1; CYCLOSPORIN A; GLYCOPROTEIN P; PHOSPHATE; TETRANDRINE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; BINDING COMPETITION; CELL MEMBRANE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; TUMOR CELL;

EID: 60749112654     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eytan G D, Regev R, Assaraf Y G. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis[J]. J Biol Chem, 1996,271 (6):3172-8.
2. Ambudkar S V, Cardarelli C O, Pashinsky I, et al. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein [J]. J Biol Chem, 1997, 272(34):21160-6.
3. Shapiro A B, Ling V. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein [J]. Eur J Biochem, 1998,254(1):189-93.
4. Stein W D. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal [J]. Physiol Rev, 1997,77 (2):545-90.
5. Martin C, Berridge G, Higgins C F, et al. Communication between multiple drug binding sites on P-glycoprotein[J]. Mol Pharmacol, 2000,58(3):624-32.
6. Ji B S, He L, Liu G Q. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1 ,an amlodipine derivative, in doxorubicin- resistant human myelogenous leukemia (K562/DOX) cells [J]. Life Sciences, 2005,77:2221-32.
7. Xiong C, Wu Y Z, Goo H C, Wang Y L. The probable pathway of low concentra tion of ouaba in on intracellular calcium elevation in guinea ventricular mycytes [J]. Chin Pharmacol Bull, 2007, 23 (10):1363-7.
8. Wang E J, Casciano C N, Clement R P, et al. Two transport binding sites of P-glyeoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence [J]. Biochim Biophys Acta, 2000,1481 (1):63-74.
9. Watanabe T, Kokubu N, Charnick S B, et al. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein [J]. Br J Pharmacol, 1997,122(2):241-8.
10. Sarkadi B, Price E M, Boucher R C, et al. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase [J]. J Biol Chem, 1992, 267 (7):4854-8.
11. Garrigos M, Mir L M, Orlowski S. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase-further experimental evidence for a multisite model[J]. Eur J Biochem, 1997,244 (2):664-73.
12. Drori S, Eytan G D, Assaraf Y G. Potentiation of anticancer-drug cytotoxicity by multi drug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability [J]. Eur J Biochem, 1995,228(3):1020-9.
13. Ford J M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers [J]. Eur J Cancer, 1996,32A (6):991-1001.
14. Jaffrezou J P, Herbert J M, Levade T, et al. Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein [J]. J Biol Chem, 1991 ,266 (29): 19858-64.
15. Avesh S, Shao Y M, Stein W D. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein[J]. Biochim Biophys Acta, 1996,1316(1):8-18.